טוען...
Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment
In recent years, successive reports have been made on large-scale cardiovascular outcome trials using novel hypoglycemic drugs. Their results have shown that sodium–glucose cotransporter 2 (SGLT2) inhibitors are hypoglycemic drugs that could potentially greatly improve the heart failure-related outc...
שמור ב:
| הוצא לאור ב: | Diabetol Int |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Singapore
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387386/ https://ncbi.nlm.nih.gov/pubmed/32802706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00445-7 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|